HUSSEIN TAWBI to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.168
-
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies. Cancer Chemother Pharmacol. 2019 12; 84(6):1289-1301.
Score: 0.129
-
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer. Cancer Chemother Pharmacol. 2022 05; 89(5):721-735.
Score: 0.039